{"title":"妊娠期肥胖与妊娠期贫血的关系:文献综述","authors":"Z. Rustembekkyzy, D. Taizhanova","doi":"10.37800/rm.3.2022.50-56","DOIUrl":null,"url":null,"abstract":"Relevance: Оbеse pregnant women have а mild inflammatory response associated with hepcidin overexpression. Inflammation affects iron metabolism by increasing hepcidin levels. Obesity and anemia are serious problems worldwide; expectant mothers often suffer from these conditions. Gravidas with obesity tend to gain more weight during pregnancy than gravidas with normal body mass index. Obesity before pregnancy is associated with a high risk in pregnancy, including hypoferremia and anemia due to iron deficiency, which are already common between expectant mother and their neonates. This review considers obesity-associated inflammatory mediator activation as a potential primary cause of iron deficiency (ID) or iron deficiency anemia (IDA) in obese pregnant women.The review aimed to summarize the current studies reporting the measurement of molecular markers of iron metabolism and inflammatory mediators in pregnant women with pregestational obesity. Methods: This review included all types of publications in English and Russian on anemia and obesity in pregnancy, published from March 2012 to March 2022. The literature search was performed in Medline, Scopus, Web of Science, Google Scholar, PubMed, and CyberLeninka databases by the following keywords: “pregnancy,” “iron deficiency,” “anemia,” “overweight,” “obesity,” “inflammation,” and “body mass index.”Results: This review assesses whether obesity-induced inflammation may contribute to the increased incidence of ID/IDA in pregnant women. Despite numerous studies, the effect of maternal weight on the risk of ID/IDA during pregnancy remains unclear. Iron status metabolism markers against inflammation are considered. PR-pregnancy obesity carries a greater risk of developing ID/IDA during pregnancy and the postnatal period for the mother and the baby. Conclusions: Thus, a more careful study of iron levels by trimester is required. The introduction of clearly defined procedures for trimester valuation of iron and inflammatory status in antenatal and postpartum consultations is necessary.","PeriodicalId":74668,"journal":{"name":"Reproductive medicine (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2022-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of pregestational obesity with anemia during pregnancy: A literature review\",\"authors\":\"Z. Rustembekkyzy, D. Taizhanova\",\"doi\":\"10.37800/rm.3.2022.50-56\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Relevance: Оbеse pregnant women have а mild inflammatory response associated with hepcidin overexpression. Inflammation affects iron metabolism by increasing hepcidin levels. Obesity and anemia are serious problems worldwide; expectant mothers often suffer from these conditions. Gravidas with obesity tend to gain more weight during pregnancy than gravidas with normal body mass index. Obesity before pregnancy is associated with a high risk in pregnancy, including hypoferremia and anemia due to iron deficiency, which are already common between expectant mother and their neonates. This review considers obesity-associated inflammatory mediator activation as a potential primary cause of iron deficiency (ID) or iron deficiency anemia (IDA) in obese pregnant women.The review aimed to summarize the current studies reporting the measurement of molecular markers of iron metabolism and inflammatory mediators in pregnant women with pregestational obesity. Methods: This review included all types of publications in English and Russian on anemia and obesity in pregnancy, published from March 2012 to March 2022. The literature search was performed in Medline, Scopus, Web of Science, Google Scholar, PubMed, and CyberLeninka databases by the following keywords: “pregnancy,” “iron deficiency,” “anemia,” “overweight,” “obesity,” “inflammation,” and “body mass index.”Results: This review assesses whether obesity-induced inflammation may contribute to the increased incidence of ID/IDA in pregnant women. Despite numerous studies, the effect of maternal weight on the risk of ID/IDA during pregnancy remains unclear. Iron status metabolism markers against inflammation are considered. PR-pregnancy obesity carries a greater risk of developing ID/IDA during pregnancy and the postnatal period for the mother and the baby. Conclusions: Thus, a more careful study of iron levels by trimester is required. The introduction of clearly defined procedures for trimester valuation of iron and inflammatory status in antenatal and postpartum consultations is necessary.\",\"PeriodicalId\":74668,\"journal\":{\"name\":\"Reproductive medicine (Basel, Switzerland)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2022-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproductive medicine (Basel, Switzerland)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37800/rm.3.2022.50-56\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive medicine (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37800/rm.3.2022.50-56","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
相关性:孕妇有与铁调素过度表达相关的轻度炎症反应。炎症通过增加铁调素水平来影响铁代谢。肥胖和贫血是世界范围内的严重问题;准妈妈经常遭受这些疾病的折磨。肥胖的孕妇在怀孕期间的体重往往比体重指数正常的孕妇增加更多。孕前肥胖与妊娠期的高风险有关,包括低铁血症和缺铁性贫血,这在准妈妈和新生儿之间已经很常见了。这篇综述认为,肥胖相关的炎症介质激活是肥胖孕妇缺铁(ID)或缺铁性贫血(IDA)的潜在主要原因。这篇综述旨在总结目前关于妊娠期肥胖孕妇铁代谢和炎症介质分子标记物测量的研究。方法:本综述包括2012年3月至2022年3月出版的关于妊娠期贫血和肥胖的所有类型的英文和俄文出版物。文献检索在Medline、Scopus、Web of Science、Google Scholar、PubMed和CyberLeninka数据库中按以下关键词进行:“妊娠”、“缺铁”、“贫血”、“超重”、“肥胖”、“炎症”和“体重指数”。“结果:本综述评估了肥胖诱导的炎症是否会导致孕妇ID/IDA发病率的增加。尽管进行了大量研究,但孕妇体重对妊娠期ID/IDA风险的影响仍不清楚。考虑了针对炎症的铁代谢标志物。PR妊娠期肥胖对母亲和婴儿来说,在妊娠期和产后期间患ID/IDA的风险更大。结论:因此,需要对妊娠期的铁水平进行更仔细的研究。在产前和产后咨询中引入明确的妊娠期铁和炎症状态评估程序是必要的。
Association of pregestational obesity with anemia during pregnancy: A literature review
Relevance: Оbеse pregnant women have а mild inflammatory response associated with hepcidin overexpression. Inflammation affects iron metabolism by increasing hepcidin levels. Obesity and anemia are serious problems worldwide; expectant mothers often suffer from these conditions. Gravidas with obesity tend to gain more weight during pregnancy than gravidas with normal body mass index. Obesity before pregnancy is associated with a high risk in pregnancy, including hypoferremia and anemia due to iron deficiency, which are already common between expectant mother and their neonates. This review considers obesity-associated inflammatory mediator activation as a potential primary cause of iron deficiency (ID) or iron deficiency anemia (IDA) in obese pregnant women.The review aimed to summarize the current studies reporting the measurement of molecular markers of iron metabolism and inflammatory mediators in pregnant women with pregestational obesity. Methods: This review included all types of publications in English and Russian on anemia and obesity in pregnancy, published from March 2012 to March 2022. The literature search was performed in Medline, Scopus, Web of Science, Google Scholar, PubMed, and CyberLeninka databases by the following keywords: “pregnancy,” “iron deficiency,” “anemia,” “overweight,” “obesity,” “inflammation,” and “body mass index.”Results: This review assesses whether obesity-induced inflammation may contribute to the increased incidence of ID/IDA in pregnant women. Despite numerous studies, the effect of maternal weight on the risk of ID/IDA during pregnancy remains unclear. Iron status metabolism markers against inflammation are considered. PR-pregnancy obesity carries a greater risk of developing ID/IDA during pregnancy and the postnatal period for the mother and the baby. Conclusions: Thus, a more careful study of iron levels by trimester is required. The introduction of clearly defined procedures for trimester valuation of iron and inflammatory status in antenatal and postpartum consultations is necessary.